{"id":44925,"title":"[Medical treatment of soft tissue sarcomas based on the histological subtype].","abstract":"A lágyrészsarcomák gyógyszeres kezelését egyre inkább a szövettani altípus határozza meg, s ez nemcsak a célzott terápiákra, hanem a citosztatikus kezelésekre is vonatkozik. Évek óta a doxorubicin és az ifosfamid a két citosztatikum, mely monoterápiában vagy kombinációban alkalmazva a leghatékonyabbnak bizonyult felnõttkori lágyrészsarcoma kezelésében. E két vegyület mellett újabb gyógyszerek hatékonysága igazolódott, mint a taxánok angiosarcomában, a gemcitabin+taxán kombináció leiomyosarcomában, a trabectedin leiomyosarcomában, valamint liposarcomában, különösen hatásos myxoid liposarcomában. A célzott kezeléseket illetõen a pazopanib (VEGFR-, c-KIT-, PDGFR-gátló) hatékonynak bizonyult leiomyosarcomában és synoviosarcomában, de hatástalan liposarcomában, a sunitinib (VEGFR-, KIT-, PDGFR-gátló) és cediranib (VEGFR-gátló) alveolaris sarcomában, a sunitinib és bevacizumab+temozolamid kombináció solitaer fibrosus tumorokban, míg a sorafenib (RAF-, VEGFR-, PDGFR-gátló) angiosarcomában. Az mTOR-inhibitorok hatékonyak PEComában (perivascular epitheloid cell tumors) és a crizotinib (ALK/MET-gátló) inflammatoricus myofibroblastos tumorokban. GIST daganatokban az imatinib (c-KIT-, PDGFR-, ABL-gátló), a sunitinib és a regorafenib (KIT-, VEGFR-, PDGFR-, RAF-gátló) hatékonysága igazolódott, míg dermatofibrosarcoma esetében az imatinibé.The medical treatment of adult soft tissue sarcomas is more and more dictated by the histological subtype, this applies to both cytotoxics and target therapies. Doxorubicin and ifosfamid are the two drugs used either in monotherapy or combination with the best established response rates in adult soft tissue sarcomas for several years. In addition to these compounds there is evidence of efficacy of new drugs such as taxanes in angiosarcoma, gemcitabine+taxanes combination in leiomyosarcomas, trabectedin in leiomyosarcomas and liposarcomas with an extremely high activity in myxoid liposarcoma. With regard to target therapy pazopanib seems especially active in leiomyosarcomas and synoviosarcomas, but totally inactive in liposarcomas, sunitinib and cediranib in alveolar soft part sarcomas, sunitinib and bevacizumab+temozolamide combination in solitary fibrous tumors, and sorafenib in angiosarcomas. mTOR inhibitors are active in PEComas (perivascular epitheloid cell tumors) and crizotinib in ALK rearranged inflammatory myofibroblastic tumors. The efficacy of imatinib and sunitinib in GIST tumors are established, and that of imatinib in dermatofibrosarcoma as well. ","date":"2014-04-08","categories":"Digestive System Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24712007","annotations":[{"name":"CD117","weight":0.906545,"wikipedia_article":"http://en.wikipedia.org/wiki/CD117"},{"name":"Sunitinib","weight":0.906012,"wikipedia_article":"http://en.wikipedia.org/wiki/Sunitinib"},{"name":"Doxorubicin","weight":0.893958,"wikipedia_article":"http://en.wikipedia.org/wiki/Doxorubicin"},{"name":"Imatinib","weight":0.883928,"wikipedia_article":"http://en.wikipedia.org/wiki/Imatinib"},{"name":"Angiosarcoma","weight":0.877753,"wikipedia_article":"http://en.wikipedia.org/wiki/Angiosarcoma"},{"name":"Liposarcoma","weight":0.835773,"wikipedia_article":"http://en.wikipedia.org/wiki/Liposarcoma"},{"name":"Cell (biology)","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Cell_(biology)"},{"name":"Histology","weight":0.799199,"wikipedia_article":"http://en.wikipedia.org/wiki/Histology"},{"name":"Mammalian target of rapamycin","weight":0.77969,"wikipedia_article":"http://en.wikipedia.org/wiki/Mammalian_target_of_rapamycin"},{"name":"Efficacy","weight":0.735569,"wikipedia_article":"http://en.wikipedia.org/wiki/Efficacy"},{"name":"Trabectedin","weight":0.732203,"wikipedia_article":"http://en.wikipedia.org/wiki/Trabectedin"},{"name":"Tumor","weight":0.72904,"wikipedia_article":"http://en.wikipedia.org/wiki/Tumor"},{"name":"Soft-tissue sarcoma","weight":0.72904,"wikipedia_article":"http://en.wikipedia.org/wiki/Soft-tissue_sarcoma"},{"name":"Sarcoma","weight":0.72904,"wikipedia_article":"http://en.wikipedia.org/wiki/Sarcoma"},{"name":"Taxane","weight":0.728515,"wikipedia_article":"http://en.wikipedia.org/wiki/Taxane"},{"name":"Tissue (biology)","weight":0.725984,"wikipedia_article":"http://en.wikipedia.org/wiki/Tissue_(biology)"},{"name":"Soft tissue","weight":0.72101,"wikipedia_article":"http://en.wikipedia.org/wiki/Soft_tissue"},{"name":"Dermatofibrosarcoma protuberans","weight":0.709663,"wikipedia_article":"http://en.wikipedia.org/wiki/Dermatofibrosarcoma_protuberans"},{"name":"Therapy","weight":0.701843,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Inflammation","weight":0.660386,"wikipedia_article":"http://en.wikipedia.org/wiki/Inflammation"},{"name":"Gastrointestinal stromal tumor","weight":0.635912,"wikipedia_article":"http://en.wikipedia.org/wiki/Gastrointestinal_stromal_tumor"},{"name":"Enzyme inhibitor","weight":0.496252,"wikipedia_article":"http://en.wikipedia.org/wiki/Enzyme_inhibitor"},{"name":"Fiber","weight":0.473927,"wikipedia_article":"http://en.wikipedia.org/wiki/Fiber"},{"name":"Pharmaceutical drug","weight":0.363278,"wikipedia_article":"http://en.wikipedia.org/wiki/Pharmaceutical_drug"},{"name":"Sorafenib","weight":0.357341,"wikipedia_article":"http://en.wikipedia.org/wiki/Sorafenib"},{"name":"Platelet-derived growth factor receptor","weight":0.342819,"wikipedia_article":"http://en.wikipedia.org/wiki/Platelet-derived_growth_factor_receptor"},{"name":"VEGF receptors","weight":0.154985,"wikipedia_article":"http://en.wikipedia.org/wiki/VEGF_receptors"},{"name":"AIDS","weight":0.133765,"wikipedia_article":"http://en.wikipedia.org/wiki/AIDS"},{"name":"Combination therapy","weight":0.130565,"wikipedia_article":"http://en.wikipedia.org/wiki/Combination_therapy"},{"name":"Orders of magnitude (mass)","weight":0.12131,"wikipedia_article":"http://en.wikipedia.org/wiki/Orders_of_magnitude_(mass)"},{"name":"Chemical compound","weight":0.0370044,"wikipedia_article":"http://en.wikipedia.org/wiki/Chemical_compound"},{"name":"Cediranib","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Cediranib"},{"name":"Pazopanib","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Pazopanib"},{"name":"Medicine","weight":0.0227187,"wikipedia_article":"http://en.wikipedia.org/wiki/Medicine"},{"name":"Evidence-based medicine","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Evidence-based_medicine"},{"name":"Anaplastic lymphoma kinase","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Anaplastic_lymphoma_kinase"},{"name":"Pulmonary alveolus","weight":0.0158689,"wikipedia_article":"http://en.wikipedia.org/wiki/Pulmonary_alveolus"},{"name":"Myofibroblast","weight":0.0158689,"wikipedia_article":"http://en.wikipedia.org/wiki/Myofibroblast"},{"name":"Royal Air Force","weight":0.0152478,"wikipedia_article":"http://en.wikipedia.org/wiki/Royal_Air_Force"},{"name":"Adult","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Adult"}]}
